Literature DB >> 8287944

Plasma lactate dehydrogenase: a marker of disease activity in cryptogenic fibrosing alveolitis and extrinsic allergic alveolitis?

S P Matusiewicz1, I J Williamson, P J Sime, P H Brown, P R Wenham, G K Crompton, A P Greening.   

Abstract

Total plasma lactate dehydrogenase (LDH) activity may be elevated in cryptogenic fibrosing alveolitis (CFA) and extrinsic allergic alveolitis (EAA), and may be a useful monitor of disease progress. In a retrospective, primary referral centre study, we compared LDH at presentation, prior to bronchoalveolar lavage BAL, and after treatment and follow-up with changes in pulmonary function, in patients with CFA, EAA and pulmonary sarcoidosis. Plasma levels of LDH at presentation in CFA (n = 47) and EAA (n = 10) were significantly higher than in patients with sarcoidosis (n = 36). LDH activity decreased in patients with improving lung function (EAA, p = 0.008; CFA, p = 0.02), whereas it increased in CFA patients with deteriorating lung function (p = 0.015). Total plasma LDH is a simple, though nonspecific test, which appears to reflect changes of disease activity in patients with CFA and EAA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8287944

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  11 in total

1.  Risk factors of relapse in pulmonary sarcoidosis treated with corticosteroids.

Authors:  Yi Zheng; Hui Wang; Qingqing Xu; Xin Yan; Yi Zhuang; Hanyi Jiang; Fanqing Meng; Yonglong Xiao; Hourong Cai; Jinghong Dai
Journal:  Clin Rheumatol       Date:  2019-03-15       Impact factor: 2.980

2.  Echogenic lymph nodes in the differential diagnosis of pediatric sarcoidosis.

Authors:  Zuhal Bayramoglu; Ibrahim Adaletli; Ezgi Kara; Manolya Acar; Selda Hancerli Torun; Ozge Kaba; Ayper Somer; Gulcin Yegen; Sidar Bagbudar; Rukiye Eker Omeroglu
Journal:  J Med Ultrason (2001)       Date:  2019-02-08       Impact factor: 1.314

3.  Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis.

Authors:  K Tsukamoto; H Hayakawa; A Sato; K Chida; H Nakamura; K Miura
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

Review 4.  Clinical use of biomarkers of survival in pulmonary fibrosis.

Authors:  Michiel Thomeer; Jan C Grutters; Wim A Wuyts; Stijn Willems; Maurits G Demedts
Journal:  Respir Res       Date:  2010-06-28

5.  Metabolic and biochemical responses of the healthy human lung to nonthoracic surgery.

Authors:  Betty Herndon; Mark Yagan; George Reisz; J C Ireland
Journal:  Lung       Date:  2007-12-08       Impact factor: 2.584

Review 6.  Toxic and other non-IgE-mediated effects of fungal exposures.

Authors:  Mark E Nordness; Michael C Zacharisen; Jordan N Fink
Journal:  Curr Allergy Asthma Rep       Date:  2003-09       Impact factor: 4.806

7.  High sensitive C-reactive protein as a systemic inflammatory marker and LDH-3 isoenzyme in chronic obstructive pulmonary disease.

Authors:  Anup N Nillawar; J S Bardapurkar; S J Bardapurkar
Journal:  Lung India       Date:  2012-01

8.  Expanded CURB-65: a new score system predicts severity of community-acquired pneumonia with superior efficiency.

Authors:  Jin-liang Liu; Feng Xu; Hui Zhou; Xue-jie Wu; Ling-xian Shi; Rui-qing Lu; Alessio Farcomeni; Mario Venditti; Ying-li Zhao; Shu-ya Luo; Xiao-jun Dong; Marco Falcone
Journal:  Sci Rep       Date:  2016-03-18       Impact factor: 4.379

Review 9.  Molecular biomarkers in interstitial lung diseases.

Authors:  Angelo De Lauretis; Elisabetta A Renzoni
Journal:  Mol Diagn Ther       Date:  2014-10       Impact factor: 4.074

10.  Examining the association between serum lactic dehydrogenase and all-cause mortality in patients with metabolic syndrome: a retrospective observational study.

Authors:  Li-Wei Wu; Tung-Wei Kao; Chien-Ming Lin; Hui-Fang Yang; Yu-Shan Sun; Fang-Yih Liaw; Chung-Ching Wang; Tao-Chun Peng; Wei-Liang Chen
Journal:  BMJ Open       Date:  2016-05-23       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.